We look forward to presenting our latest intercom solutions at NAB NY 2024,” said Gary Rosen, Vice President of Global Sales ...

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced ...

Broadcast intercom systems play a crucial role in coordinating complex productions and ensuring clear communication ... Read ...

On Tuesday, Pliant Therapeutics Inc (PLRX) stock saw a modest uptick, ending the day at $11.33 which represents a slight increase of $0.01 or 0.09% from the prior close of $11.32. The stock opened at ...

Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) and keeping the price target at $38.00. Ed Arce has given his Buy rating due to a ...

Pliant Therapeutics' stock initially surged, but has since fallen due to mixed trial results and competitive pressures. Bexotegrast showed promising results in IPF and PSC trials, but dose ...

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel ...

Built for the Israeli government by Israel Desalination Enterprises, or IDE Technologies, at a cost… In December, geneticists announced that they’d made a major advance in engineering rice ...

Sify Technologies becomes become an NVIDIA colocation partner with the NVIDIA DGX-Ready Data Center program, certified for liquid cooling. Sify stock is moving on heavy trading volume following ...

SOUTH SAN FRANCISCO, CA - Pliant Therapeutics, Inc. (NASDAQ:PLRX), a biopharmaceutical company, announced on Monday an update to its corporate bylaws to reflect recent changes in Delaware law. The ...

Pliant Technologies, a leading provider of professional wireless intercom solutions, has announced that it will be showing a ...